XML 52 R37.htm IDEA: XBRL DOCUMENT v3.20.4
SIGNIFICANT ACCOUNTING POLICIES, Part 1 (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2020
Jul. 31, 2020
Mar. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Fair Value of Financial Instruments [Abstract]          
Cash and cash equivalents $ 23,066,301     $ 23,066,301 $ 18,271,352
Cash and Cash Equivalents [Abstract]          
Restricted cash 1,000,000     1,000,000 0
Valuation of Long-Lived Assets and Intangible Assets [Abstract]          
Goodwill impairment loss       0 0
Disaggregation of Revenue [Abstract]          
Total revenues       32,470,197 34,464,032
Contract Liabilities [Abstract]          
Deferred revenue 1,606,997     1,606,997 125,000
Earned grant revenue       $ 100,000  
Term over which revenue will be recognized       12 months  
SARS-CoV-2 Ag System [Member]          
Contract Liabilities [Abstract]          
Maximum amount of development agreement   $ 600,000      
Multiplex DPP Respiratory Antigen Panel Point-of-care Test system [Member]          
Contract Liabilities [Abstract]          
Maximum amount of development agreement 12,700,000        
Forecast [Member]          
Contract Liabilities [Abstract]          
Earned grant revenue     $ 800,000    
Government Grant Income [Member]          
Disaggregation of Revenue [Abstract]          
Total revenues       $ 2,018,924 654,744
Government Grant Income [Member] | SARS-CoV-2 Ag System [Member]          
Disaggregation of Revenue [Abstract]          
Total revenues       400,000  
Government Grant Income [Member] | Multiplex DPP Respiratory Antigen Panel Point-of-care Test system [Member]          
Disaggregation of Revenue [Abstract]          
Total revenues       1,600,000  
Level 2 [Member]          
Fair Value of Financial Instruments [Abstract]          
Fair value of total debt 20,000,000     20,000,000 20,000,000
Carrying value 18,200,000     18,200,000 17,600,000
Money Market Funds [Member] | Level 1 [Member]          
Fair Value of Financial Instruments [Abstract]          
Cash and cash equivalents $ 14,800,000     $ 14,800,000 $ 16,000,000.0
Minimum [Member]          
Fixed Assets [Abstract]          
Estimated useful lives of fixed assets       3 years  
Product Revenue [Abstract]          
Revenue, payment terms       30 days  
Maximum [Member]          
Fixed Assets [Abstract]          
Estimated useful lives of fixed assets       7 years  
Product Revenue [Abstract]          
Revenue, payment terms       60 days